Video

NETs: A Personalized Approach

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Imiage of two doctors with text.
ctDNA-Guided Therapy May Improve Breast Cancer Outcomes
Image of thumbnail.
What Patients With Genitourinary Cancers Should Know After ASCO 2025
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Enhertu Combo May Offer Longer Control for HER2+ Breast Cancer
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Targeting ESR1 Mutations Early May Improve Outcomes in Breast Cancer
Image of woman.
Understanding the Side Effects of RLY-2608 in HR+, HER2– Breast Cancer
Image of Dr. Deville.
What are the Long-Term Side Effects of Proton Therapy in Prostate Cancer?
Image of Doctor.
Long-Term Prostate Cancer Data Highlights Risk and Survivorship Needs
Image of Dr. Tagawa.
Breaking Down the Benefits of Clinical Trial Participation in Cancer Care
Picture of Dr. Pouneh Razavi
Breast MRI Offers Sensitive Imaging for High-Risk and Diagnosed Patients
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Crafting an Individual Treatment Plan for Patients With Prostate Cancer
Related Content
image of woman.
June 17th 2025

From Navigating the Unknown to Building a Movement: My DCIS Journey

Julia Stalder
The bad news is you have ductal carcinoma in situ. The good news is that DCIS is the best type of breast cancer to get.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Image of woman.
June 17th 2025

Understanding the Importance of the DESTINY-Breast09 Trial in HER2+ Breast Cancer

Ryan Scott
Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic breast cancer should know.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Sara Gideon, nurse practitioner, is a compassionate oncology nurse who supports patients with cancer: © stock.adobe.com.
June 15th 2025

Where Compassion Meets Care in Breast Cancer

Margaret Valenti, DNP, RN, AHN-BC, MEDSURG-BC
Sara Gideon, nurse practitioner, is a compassionate oncology nurse who supports patients with cancer, streamlines care and leads with dedication.
Image of debbie.
June 13th 2025

Survivorship, the Hardest Part After Cancer?

Debbie Legault
Survivorship after cancer can be harder than treatment. My daughter faces lasting side effects, fear, and uncertainty while building a life she hopes to live fully.